Cryopreservation

Reproductive lifespans are limited and there is no current way to reverse ovarian aging, which is why earlier egg freezing is key to better future outcomes when family planning, according to a speaker at the Mount Sinai Women’s Health Forum.

DENVER — In a survey of U.S. medical trainees, many respondents reported concerns about their or their partner’s future fertility and expressed interest in oocyte cryopreservation, but were unaware of available treatment options.

Prior testosterone exposure did not impact oocyte cryopreservation outcomes among transgender and gender-diverse adolescents and young adults, according to a research letter published in Obstetrics & Gynecology.

Women with poor ovarian response to stimulation had higher likelihood of using frozen oocytes after planned cryopreservation vs. women normal response, particularly among women aged 30 to 39 years, according to cohort study results.

Young patients with cancer preparing to undergo treatment that may impair reproductive function should receive prompt counseling on fertility preservation options and referral to specialists, according to Douglas B. Fair, MD, MS.

An increasing body of evidence shows that using younger, less heavily pretreated T cells results in more effective chimeric antigen receptor T-cell therapies.

Semen cryopreservation is a viable method of fertility preservation for feminizing transgender individuals, according to findings published in Pediatrics.